---
author: Nate Barksdale
pubDatetime: 2008-09-26
modDatetime: 2025-03-31T16:30:12Z
title: Cancer study fail
slug: cancer-study-fail
featured: false
draft: false
description: The challenge of publishing negative trial results is a deep issue in the scientific community.
emoji: ðŸ“‰
tags:
  - ðŸŒ Culture-Making.com
  - âš•ï¸ Medicine
  - âš–ï¸ Ethics
  - âš–ï¸ Law
  - ðŸ”„ Commitment
haiku: |
  Trials lost in silence,  
  Knowledge buried in shadows,  
  Truth must find the light.
coordinates: [40.7128, -74.0060]
---

There must be a culturally-creative way around this sticking point of human (and corporate) nature. Required reporting, as with industrial accidents? Anonymous publication? A Nobel Prize for the best idea that didn't pan out?
"[Fewer Than 1 in 5 Cancer Trials Published," [NYTimes.com Ideas Blog](http://ideas.blogs.nytimes.com/2008/09/26/fewer-than-1-in-5-cancer-trials-published/), 26 September 2008

> **Medicine |** A [medical journal](http://web.archive.org/web/20081201213337/http://www.theoncologist.com/cgi/reprint/theoncologist.2008-0133v1) says a vast amount of cancer research is never published, perhaps because clinical trials show the drugs or treatments didnâ€™t work. That deprives other researchers of valuable knowledge. Why this happens: scientists, medical journals and drug firms all have an interest in touting breakthroughs and not failure. [[Business Week](https://www.google.com/search?q=%22%5BBusiness%20Week%22%20businessweek.com), [Oncologist](http://web.archive.org/web/20081201213337/http://www.theoncologist.com/cgi/reprint/theoncologist.2008-0133v1)]
